Betamethasone Dipropionate Ointment, Augmented
Product Images NDC 68180-947
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Betamethasone Dipropionate (NDC 68180-947). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
50g-carton (05e2d282 5434 4495 9832 67731f9e7634 02)
Tube Label (05e2d282 5434 4495 9832 67731f9e7634 03)
Betamethasone Dipropionate Ointment USP (Augmented) is a medication used to treat skin conditions such as eczema and psoriasis. The ointment is made of a cement base of propylene glycol and white wax, along with other ingredients. The recommended dosage is to apply a thin layer of the ointment to the affected skin once or twice daily without occlusion. This medication should only be used as directed and is for topical use only. It should be stored at 25°C with excursions permitted between 15° and 30°C. This ointment is manufactured by Lupin Pharmaceuticals and the strength of the medication is expressed as betamethasone. See packaging for lot number and expiration date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.